The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The value of HbA1c as a tool to determine glycemic control in patients with diabetes and renal failure has not been well studied, the same accepted normal ranges for HbA1c are applied to all patients with diabetes regardless of their renal function. We would like to evaluate the use of HbA1c as a tool of assessing long term glycemic control in this subgroup of patients with diabetes and evaluate the effect of dialysis on HbA1c

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

NCT05695573

Diabetic Nephropathy

COMPLETED

Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus

NCT07169786

CKD Stage 1-4 Diet Pattern Analysis Type2 Diabetes Mellitus

NOT_YET_RECRUITING

Insulin Resistance, Sarcopenia and Plasma BAIBA Levels

NCT04309201

Sarcopenia Insulin Resistance

COMPLETED

The Incretin Effect in Patients With Kidney Impairment

NCT01327378

Renal Insufficiency, Chronic

COMPLETED

Diabetic Patients With End-Stage Renal Disease

NCT00435786

Diabetes End-Stage Renal Disease Cardiovascular Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal renal function

No interventions assigned to this group

Stage 2 and 4 and 5 chronic kidney disease

No interventions assigned to this group

End stage renal disease on hemodialysis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients \>18 years of age with type 1 or 2 diabetes who show competence in home glucose monitoring and are willing to commit to doing the testing

Exclusion Criteria

* Pregnancy
* Having received a blood transfusion with in the preceding three months
* Known to have any hereditary or hemolytic anemia
* On a medication known to interfere with HbA1c assay (opiates, acetaminophen, vitamin C, vitamin E) - we will allow patients to be on asprin as almost all patients with diabetes are on this drug.
* Having a blood hemoglobin \<7 mg/dl
* Bilirubin level \>20mg/dL or a triglyceride level \> 250mg/dL
* Alcohol addiction

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No